Literature DB >> 2546815

Specific binding of okadaic acid, a new tumor promoter in mouse skin.

M Suganuma1, M Suttajit, H Suguri, M Ojika, K Yamada, H Fujiki.   

Abstract

The tumor promoter okadaic acid binds specifically to a particulate as well as a cytosolic fraction of various mouse tissues, e.g., skin, brain, lung and colon. The KD value was 21.7 nM for receptors in the particulate fraction and 1.0 nM for those in the cytosolic fraction of mouse skin. The specific binding of [3H]okadaic acid to the particulate fraction of mouse skin was inhibited dose-dependently by okadaic acid, but not okadaic acid tetramethyl ether, an inactive compound, or by other tumor promoters, such as 12-O-tetradecanoylphorbol-13-acetate and teleocidin. The results suggest a new pathway of tumor promotion mediated through the okadaic acid receptor(s).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546815     DOI: 10.1016/0014-5793(89)80807-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  Algal biotoxins of marine origin: new indications from the European Union.

Authors:  R Poletti; A Milandri; M Pompei
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Regulation of collagenase gene expression by okadaic acid, an inhibitor of protein phosphatases.

Authors:  S J Kim; R Lafyatis; K Y Kim; P Angel; H Fujiki; M Karin; M B Sporn; A B Roberts
Journal:  Cell Regul       Date:  1990-02

3.  Regulation of natural killer cell-mediated cytotoxicity by serine/threonine phosphatases: identification of a calyculin A-sensitive serine/threonine kinase.

Authors:  A Bajpai; Z Brahmi
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity.

Authors:  S Yoshizawa; R Matsushima; M F Watanabe; K Harada; A Ichihara; W W Carmichael; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Mechanisms of action of okadaic acid class tumor promoters on mouse skin.

Authors:  H Fujiki; M Suganuma; S Yoshizawa; S Nishiwaki; B Winyar; T Sugimura
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

6.  Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.

Authors:  K Nishio; Y Sugimoto; K Nakagawa; S Niimi; Y Fujiwara; M Bungo; K Kasahara; H Fujiki; N Saijo
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

7.  Comparative study of Domoic Acid and Okadaic Acid induced-chromosomal abnormalities in the Caco-2 cell line.

Authors:  Pinto-Silva Carvalho; R Catian; Serge Moukha; William G Matias; Edmond E Creppy
Journal:  Int J Environ Res Public Health       Date:  2006-03       Impact factor: 3.390

8.  Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1.

Authors:  A Sakai; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1991-05

9.  Structure-function relationships of microcystins, liver tumor promoters, in interaction with protein phosphatase.

Authors:  R Nishiwaki-Matsushima; S Nishiwaki; T Ohta; S Yoshizawa; M Suganuma; K Harada; M F Watanabe; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1991-09

Review 10.  The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-20       Impact factor: 4.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.